Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Alvarez

Showing results (61-70 of 76) with videos related to

Pageof 8
Sort By:
Nature|May 18, 2018
Microglial control of astrocytes in response to microbial metabolitesVeit Rothhammer, Davis M Borucki, Emily C Tjon, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activationKarin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2022
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical PracticePeter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation SyndromePeter Valent, Cem Akin, Patrizia Bonadonna, et al.
American Journal of Human Genetics|January 9, 2021
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosisGabriella Galatà, Andrés C García-Montero, Thomas Kristensen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαTPeter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM ConsortiumPeter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
Journal of the American Academy of Dermatology|February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER studyFrank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Pageof 8

Showing results (61-70 of 76) with videos related to

Sort By:
Pageof 8
Nature|May 18, 2018
Microglial control of astrocytes in response to microbial metabolitesVeit Rothhammer, Davis M Borucki, Emily C Tjon, et al.
The Journal of Allergy and Clinical Immunology|December 16, 2025
Prevalence of KIT D816V in anaphylaxis or systemic mast cell activationKarin Hartmann, Ivan Alvarez-Twose, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology|June 21, 2020
Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinionsPeter Valent, Cem Akin, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 28, 2022
Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical PracticePeter Valent, Karin Hartmann, Juliana Schwaab, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation SyndromePeter Valent, Cem Akin, Patrizia Bonadonna, et al.
American Journal of Human Genetics|January 9, 2021
Genome-wide association study identifies novel susceptibility loci for KIT D816V positive mastocytosisGabriella Galatà, Andrés C García-Montero, Thomas Kristensen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 12, 2023
The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαTPeter Valent, Gregor Hoermann, Patrizia Bonadonna, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 27, 2022
Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM ConsortiumPeter Valent, Karin Hartmann, Patrizia Bonadonna, et al.
Journal of the American Academy of Dermatology|February 14, 2026
Avapritinib improves cutaneous involvement in patients with indolent systemic mastocytosis: Results from the randomized, phase 2, interventional PIONEER studyFrank Siebenhaar, Sigurd Broesby-Olsen, Mariana Castells, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 8, 2021
COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)Patrizia Bonadonna, Knut Brockow, Marek Niedoszytko, et al.
Pageof 8